| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Genetics, Vol. 175, 1229-1240, March 2007, Copyright © 2007
doi:10.1534/genetics.106.063685
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Bioscience and Biotechnology, Drexel University, Philadelphia, Pennsylvania 19104
1 Corresponding author: Department of Bioscience and Biotechnology, Drexel University, Philadelphia, PA 19104.
E-mail: fe22{at}drexel.edu
| ABSTRACT |
|---|
|
|
|---|
Histone-modifying enzymes termed histone acetyltransferases (HATs) are directly involved in promoting chromatin decondensation, generally resulting in positive effects on gene activation (STERNER and BERGER 2000; BOTTOMLEY 2004). HATs enymatically act to catalyze the transfer of an acetyl group from acetyl-CoA to the
-amino group of specific and conserved positively charged lysine residues within the N-terminal tails of nucleosomal histones. This modification weakens histone–DNA and neighboring nucleosomal contacts to promote chromatin disruption that, in turn, facilitates factor binding and transcriptional activation (STERNER and BERGER 2000; ROTH et al. 2001). A second way in which HATs regulate gene activity is through their distinct substrate preference for specific histone, lysine, and gene targets, allowing HATs to generate different acetylation patterns within the genome (STRAHL and ALLIS 2000; BERGER 2001, 2002; FISCHLE et al. 2003; HAKE et al. 2004). Such distinct HAT-generated histone and lysine acetylation patterns, as well as additional histone modifications, have been postulated by the "histone code hypothesis" to serve as epigenetic marks that control gene expression by providing recognition sites for downstream regulatory factors (NOWAK and CORCES 2000; RICE and ALLIS 2001; FISCHLE et al. 2003; BOTTOMLEY 2004). Specific HATs are also capable of generating specific local or global acetylation patterns (HEBBES et al. 1994; ELEFANT et al. 2000a,b; FERNANDEZ et al. 2001; SMITH et al. 2001; HO et al. 2002; COOKE et al. 2004) that influence gene expression profiles. The ability of certain HATs to acetylate nonhistone regulatory proteins adds an additional layer of complexity to their many functions (STERNER and BERGER 2000). Finally, histone acetylation is a reversible process that is achieved by histone deacetylase enzymes, generally resulting in gene silencing (ALLAND et al. 1997). Thus, histone acetylation directly influences gene programming during development as it permits only certain portions of the genome to be activated in any given developmental stage, cell, or tissue type (WOLFFE and DIMITROV 1993; PATTERTON and WOLFFE 1996). Understanding how these differentially folded chromatin domains are created and maintained in specific cell types is of central importance to the study of biological regulation during development.
Previous reports have shown that Drosophila contains a number of human HAT homologs that belong to each of the three major HAT superfamilies: GNAT (SMITH et al. 1998), MYST (GRIENENBERGER et al. 2002), and p300/CREB-binding protein (CBP) (AKIMARU et al. 1997; LUDLAM et al. 2002). Their genetic analysis in Drosophila has provided essential information on the role of acetylation in a wide variety of developmental cellular processes. To gain further understanding into the developmental roles of HATs and acetylation during development, we sought to identify and characterize human HAT homologs in Drosophila (Dmel\HATs), with the reasoning that we could use such Dmel\HATs to decipher human-relevant HAT function in the multicellular Drosophila model setting (CHIEN et al. 2002). We chose to focus our studies on TIP60, as this HAT is representative of the MYST HAT superfamily and carries out previously described diverse roles essential for cellular function. Tip60 (tat-interactive protein, 60 kDa) was identified as part of a multimeric protein complex (ALLARD et al. 1999; IKURA et al. 2000; DOYON and COTE 2004) that regulates its activity in many essential cellular processes, including apoptosis (LUDLAM et al. 2002; LEGUBE et al. 2004), DNA repair (IKURA et al. 2000; BIRD et al. 2002; MORRISON and SHEN 2005), cell cycle progression (CLARKE et al. 1999), developmental cell signaling (CEOL and HORVITZ 2004), ribosomal gene transcription (REID et al. 2000; HALKIDOU et al. 2004), and histone variant exchange during DNA repair (KUSCH et al. 2004). However, despite the importance of Tip60 in many essential cell processes, it has yet to be studied extensively in a multicellular in vivo model setting, and thus its developmental, tissue, and cell-type-specific roles remain to be explored.
Here, we report the first isolation and developmental characterization of a Drosophila HAT gene (Dmel\TIP60) that is the homolog of the human HAT gene TIP60. We present evidence that Dmel\TIP60 is differentially expressed throughout Drosophila development, with expression levels significantly peaking during embryogenesis. Using RNA interference (RNAi), we show that reducing endogenous Dmel\TIP60 expression in a Drosophila embryonic cell line results in cellular defects and lethality. Finally, we confirm this detrimental in vitro effect in vivo by using an inducible GAL4-targeted RNAi system in Drosophila and demonstrating that early ubiquitous and mesoderm-specific reduction of Dmel\TIP60 expression results in total lethality of the developing flies. Our results suggest a potential mechanism underlying HAT regulation involving developmental control of HAT expression profiles and demonstrate an essential role for Dmel\TIP60 during multicellular development.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Real-time PCR analysis of staged Drosophila RNA:
Total RNA was isolated from staged Canton-S. Drosophila melanogaster (12- to 24-hr embryo, first instar larvae, second instar larvae, third instar larvae, pupae, and adult flies) were treated using TRIzol (Invitrogen) and treated twice with DNA-free (Ambion, Austin, TX) to remove DNA. First-strand cDNA was prepared using the SuperScript II reverse transcriptase kit (Invitrogen) according to the manufacturer's instructions with 1 µg total RNA and 15 ng/µl of random hexamer primers (Roche). Primer sets for Dmel\ELP3 (forward primer 5'-TCC CCA TGC CGC TTG TTA GT-3' and reverse primer 5'-CCG CCA TTG GCC ACA TAG TC-3') amplified a 190-bp fragment. Primer sets for Dmel\TIP60 (forward primer 5'-CAC AGC GCC ACC ATT CCC TA-3' and reverse primer 5'-CCA GAT TGT TGC CAT TCA C-3') amplified a 202-bp fragment. All PCR reactions were carried out in triplicate in 20-µl total reaction volumes containing 0.5 units Taq (QIAGEN, Chatsworth, CA), 1 µl cDNA (from the RT reaction described above), 250 µM dNTPs (Amersham Pharmacia Biotech), 500 nM for each forward and reverse primer, and 0.25x SYBR green I dye [Molecular Probes (Eugene, OR) and Invitrogen]. The PCR was carried out in 96-well microtiter plates and the cycling conditions were 40 cycles at 95° for 45 sec, 55° for 45 sec, and 72° for 1 min with plate readings recorded after each cycle. All results were converted to real cDNA quantities by comparison to a standard curve generated with serial dilutions of either Dmel\TIP60 or Dmel\ELP3 cDNA TOPO pCR2.1 clones. All data analysis was performed using Opticon2 system software (MJ Research, Watertown, MA).
RNAi and control Dmel\TIP60 constructs:
To create the inverted-repeat Dmel\TIP60/RNAi pUAST construct, a 613-bp target RNAi sequence was amplified by PCR using primer sets specific for the Dmel\TIP60 cDNA sequence and the Dmel\TIP60 cDNA TOPO pCR2.1 clone as template. The forward primer 5'-GGA GAA TTC GCA CTG GAG TGA CCA CGC CAC AGC GCC-3' contained an EcoRI site (italics). The reverse primer 5'-GCA TAA GAG CGG CCG CAT CTA CTG TAC TTC AGG CAG AAC TCG CAG ATG-3' contained a NotI site (italics) and a 5-bp polylinker sequence (underlined). PCR reactions were performed as described above for Dmel\HAT cloning. The correct-size PCR-generated fragment was cloned in the sense direction into EcoRI/NotI sites in the pUAST vector under the control of the UAS promoter. This construct was designated Dmel\TIP60/pUAST.1. The same target fragment described above was next PCR amplified using the Dmel\TIP60 cDNA TOPO pCR2.1 clone as template. The forward primer 5'-GGA TCT AGA GCA CTG GAG TGA CCA CGC CAC AGC GCC-3' contained a XbaI site (italics) and the reverse primer 5'-GCA TAA GAG CGG CCG CCT GTA CTT CAG GCA GAA CTC GCA GAT G-3' contained a NotI site (italics). The PCR-generated fragment was cloned in an antisense orientiation into NotI and XbaI sites of the Dmel\TIP60/pUAST.1, thereby creating the inverted-repeat Dmel\TIP60/RNAi/pUAST construct. To create the sense–sense Dmel\TIP60/control construct, the same target RNAi sequence was PCR amplified with the following primers: the forward primer 5'-GCA TAA GAG CGG CCG CGC ACT GGA GTG ACC ACG CCA CAG CGC C-3' contained a NotI site (italics) and the reverse primer 5'-GCA TCT AGA CTG TAC TTC AGG CAG AAC TCG CAG ATG-3' contained a XbaI site (italics). The PCR-generated fragment was cloned in a sense orientiation into the NotI and XbaI sites of Dmel\TIP60/pUAST.1, creating a sense–sense Dmel\TIP60/control/pUAST construct. The PCR-generated polylinker and the common NotI restriction site that joined the two target Dmel\TIP60 repeat fragments served as the "hinge" region of the hairpin in both Dmel\TIP60/RNAi/pUAST and Dmel\TIP60/control/pUAST constructs. All cloning was carried out using standard procedures except that SURE 2 competent bacterial cells (Stratagene, La Jolla, CA) were used for all bacterial transformations to prevent recombination from occurring.
Dmel\TIP60/RNAi and control constructs for transient cell transfection were created by digesting the Dmel\TIP60/RNAi/pUAST and Dmel\TIP60/control/pUAST constructs with EcoRI and XbaI restriction enzymes, gel purifying (QIAGEN) the released fragments, and subcloning each fragment into EcoRI and XbaI restriction sites within the pAc5.1/V5-HisA vector (Invitrogen). These constructs were designated Dmel\TIP60/RNAi/pAc5.1 and Dmel\TIP60/control/pAc5.1.
Cell culture and transfection:
D.Mel-2 cells [GIBCO BRL (Gaithersburg, MD) and Invitrogen] were grown in Drosophila–serum-free media (SFM) (Invitrogen) supplemented with 90 ml/liter of 200 mM L-glutamine (GIBCO and Invitrogen). The cells were grown in a 28°, nonhumidified, ambient-air-regulated incubator (Torrey Pines Scientific) and subcultured every 3–4 days to maintain exponential growth. On day 3 postsubculture, the cells were seeded to 50–60% confluence into 35-mm plates in 2.0 ml Drosophila–SFM with L-glutamine. After an overnight incubation at 28°, the cells were incubated with the transfection mixture containing 2 µg plasmid DNA, 8 µl Cellfectin (Invitrogen), and 500 µl Drosophila–SFM without L-glutamine for 3 hr. After removal of the transfection mixture and addition of 2 ml of Drosophila–SFM with L-glutamine, each plate was incubated at 28° and observed after 24, 48, and 72 hr. As a transfection efficiency control, separate plates of cells were transfected with pAC5.1/V5-His/lacZ (Invitrogen), cells were stained using the ß-Gal staining kit (Invitrogen) according to the manufacturer's instructions, and blue cells were counted to determine the transfection efficiency. All transient transfections were performed in triplicate.
Semiquantitative RT–PCR:
Total RNA either from a plate of transfected cells or from three third instar larvae progeny from a homozygous Dmel\TIP60/RNAi or control x GAL4 337 cross was isolated using TRIzol (Invitrogen) and twice treated with DNA-free (Ambion) to remove DNA. First-strand cDNA was prepared using the SuperScript II reverse transcriptase kit (Invitrogen) according to the manufacturer's instructions with 1 µg total RNA and 15 ng/µl of random hexamer primers (Roche). PCR reactions were performed in a 40-µl total volume containing 1 unit Taq (QIAGEN), 1 µl cDNA template, 250 µM dNTPs (Amersham Pharmacia Biotech), and 500 nM of each forward and reverse primer. The cycling conditions were 36 cycles of 95° for 45 sec, 55° for 45 sec, and 72° for 1 min. The forward primer (5'-TGG TAT TTC TCA CCC TAT CC-3') and the reverse primer (5'-CAA TGA GCA GCT TGC CGT AG-3') amplified a 427-bp fragment that corresponded to position 1407–1833 within the cDNA Dmel\TIP60 sequence.
Creation of P-element-transformed fly lines:
P-element germline transformations with pUAST constructs were performed as previously described (ELEFANT and PALTER 1999) to create fly lines containing Dmel\TIP60/RNAi or Dmel\TIP60/control pUAST constructs. To determine on which chromosome the P-element inserted, lines heterozygous for the TM3 and TM6 balancers were mated to w1118 flies, and segregation of the w+ marker was scored: if segregation of w+ was neither with the third chromosome balancer nor with a sex chromosome, it was inferred to segregate with the second chromosome. Balancer chromosomes were subsequently crossed away by successive mating to w1118. Multiple, independent fly lines were created for each construct as the level of gene expression is dependent upon the chromosomal location of the P element, which occurs randomly.
Drosophila stocks and RNAi crosses:
For this study, the following P{pUAST}/P{pUAST} flies containing either Dmel\TIP60/RNAi or control constructs were created as described above. The GAL4 lines used were y1 w*; P{Act5C-GAL4}25FO1/CyO (donated by the Bloomington Stock Center, no. 4414; Y. Hiromi), w*;P{GawB}how24B (BRAND and PERRIMON 1993), and GAL4 line 337 (ELEFANT and PALTER 1999). All crosses were performed using three males and three newly eclosed virgin females in narrow plastic vials (Applied Scientific) with yeasted Drosophila media (Jazz-Mix, Fisher Scientific) at 25°.
| RESULTS |
|---|
|
|
|---|
Analysis of the conceptual translation products for both Dmel\TIP60 and Dmel\ELP3 provided evidence that these Drosophila genes are homologs of the human HATs TIP60 and ELP3. First, alignments between each Dmel\HAT and its human HAT counterpart demonstrated significant homology over their entire coding sequences: Dmel\Tip60 is 58% identical/67% similar and Dmel\Elp3 is 82% identical/91% similar (Figure 1, A and B; Figure 2, A and B). Additionally, the Dmel\Tip60 transcript was found to contain an open reading frame of 1626 bp, encoding a protein of 541 aa with a predicted molecular mass of 61.2 kDa, in good agreement with the apparent molecular mass of human TIP60 (IKURA et al. 2000). The ELP3 transcript contained an ORF of 1659 bp, producing a protein of 552 aa with a predicted molecular mass of 62.8 kDa, shown to be the approximate molecular mass for the human Elp3 protein (HAWKES et al. 2002). Finally, structural protein data obtained using the conserved domain architecture retrieval tool (CDART) at NCBI revealed that the predicted protein domains specific for Dmel\Tip60 and Dmel\Elp3 and their locations within each Dmel\HAT protein are highly conserved between human and Dmel\HAT counterparts (Figure 1, A and B; Figure 2, A and B). Both Drosophila and human MYST family member Tip60 contain an N-terminal chromodomain and a C-terminal MYST domain, while both Drosophila and human GNAT family member Elp3 contain an N-terminal putative histone demethylation domain and a C-terminal HAT domain. As expected, each of these conserved domains showed significant homology to one another: for dTip60, the chromodomain is 70% identical/87% similar and the MYST domain is 80% identical/89% similar; and, for Dmel\Elp3, the HAT domain is 85% identical/93% similar while the putative histone demethylase domain is 88% identical/94% similar to its human homolog counterparts. Protein sequence analysis of a number of Dmel\Tip60 and Dmel\Elp3 homologs in a variety of different species in addition to humans, including Mus musculus, Danio rerio, Caenorhabditis elegans, Arabidopsis thaliana, and Saccharomyces cerevisiae, demonstrated that such HAT conservation for both Dmel\Tip60 and Dmel\Elp3 is evolutionarily well conserved (Figure 2, A and B). The significant sequence and structural similarity between each Dmel\HAT and its human HAT counterpart strongly indicates that these newly isolated Drosophila genes are homologs of human TIP60 and ELP3.
|
|
|
We chose to initially focus our studies on Tip60, as this HAT has been previously reported to play a wide range of biological roles essential for numerous cellular processes (CLARKE et al. 1999; IKURA et al. 2000; REID et al. 2000; BIRD et al. 2002; CEOL and HORVITZ 2004; HALKIDOU et al. 2004; KUSCH et al. 2004; LEGUBE et al. 2004). To create the Dmel\TIP60/RNAi construct, we selected a 613-bp RNAi nonconserved target sequence specific for Dmel\TIP60 (Figure 4A). BLAST searches using this sequence ensured nonredundancy within the genome. The chosen Dmel\TIP60 cDNA fragment was cloned into the inducible expression vector (pUAST) under the control of GAL4–UAS-binding sites in a sense–antisense inverted gene arrangement predicted to form a double-stranded RNA hairpin that would induce an RNAi response. This plasmid was designated the Dmel\TIP60/RNAi construct (Figure 4B). A control construct was created in which the same RNAi target sequences were cloned into a sense–sense orientation so that the control construct would not induce RNAi. This plasmid was designated the Dmel\TIP60/control construct (Figure 4C). Both the sense–antisense and sense–sense sequences in each of the constructs were separated by a short polylinker that served as the "hinge" region of the hairpin arrangement.
|
50–70% lethality 24 hr post-transfection (Figure 5D). Additionally, Dmel\TIP60/RNAi induction appeared to disrupt mitotic cell cycle progression, as those cells that did survive were larger than the wild-type and control cells and appeared to be arrested during cytokinesis. None of these defects were observed in cells transfected with the Dmel\TIP60/control construct (Figure 5C). These results demonstrate that Dmel\TIP60/RNAi production in a Drosophila embryonic cell line results in cellular defects and lethality, supporting an essential role for Dmel\TIP60 in early development.
|
Dmel\TIP60 is essential for Drosophila development:
To confirm and further explore our finding that Dmel\TIP60 is required for cell viability, we used a GAL4-targeted RNAi knockdown system to induce silencing of endogenous Dmel\TIP60 expression in the Drosophila multicellular model setting. Flies were transformed with our Dmel\TIP60/RNAi and control GAL4-inducible pUAST constructs, and three independently derived transgenic fly lines with insertions for each of the constructs were chosen for use. The insertions were homozygous viable and did not cause any observable mutant phenotypes in the absence of GAL4 induction.
On the basis of our previous findings that the actin promoter (Act5C) induced potent Dmel\TIP60 RNAi knockdown in the Drosophila cell culture line, we chose to induce Dmel\TIP60/RNAi and control transgene expression in the fly using the Act5c-Gal4 driver strain (Bloomington Stock Center no. 4414), as this actin driver expresses robust levels of GAL4 constitutively and ubiquitously early in embryogenesis (CHAVOUS et al. 2001; ROLLINS et al. 2004). We found that when the Act5c-Gal4 driver was used to induce transgene expression at 25°, each of the three Dmel\TIP60/RNAi insertion lines reduced survival to 0% that of all three Dmel\TIP60/control insertion lines (Table 1). In each case, lethality for the majority of flies occurred during early pupal development, which was the latest stage that flies were able to survive. The flies that did survive until this stage showed essentially wild-type development. As an internal control, Act5c flies are hemizygous for the GAL4 driver over a CyO balancer chromosome (P{Act5c-Gal4}y/CyO y+) and thus
50% of flies are expected to eclose due to no GAL4 production in half of the progeny in any given cross. Thus, to determine whether a significant percentage of flies died earlier than the pupal stage, the total number of dead, noneclosed GAL4+ (y;Cy+) pupae was compared to the total number of non-RNAi-induced GAL4– (y+;Cy) flies that eclosed over a 10-day period. We found that although no Dmel\TIP60 RNAi-induced GAL4+ (y;Cy+) flies were found to eclose, the number of dead pupae was significantly lower than the number of viable GAL4– (y+;Cy) flies for one of the Dmel\TIP60/RNAi insertion lines tested. A comparison of the number of such "missing" dead pupae with the total number of eclosed GAL4– (y+;Cy) flies demonstrated that for Dmel\TIP60/RNAi/A, 24% of the Dmel\TIP60/RNAi-induced flies must have died sometime earlier than pupal development (data not shown). The variation in lethality observed between fly lines is likely due to position effects on transgene expression. Our results demonstrate that early and ubiquitous induction of Dmel\TIP60/RNAi in the fly using an actin-specific GAL4 driver results in total lethality for each of the three Dmel\TIP60/RNAi insertions tested, supporting an essential role for Dmel\TIP60 in multicellular development and the feasibility of our inducible GAL4-targeted HAT/RNAi knockdown system in Drosophila.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Our analysis of Dmel\TIP60 and Dmel\ELP3 expression levels using real-time PCR demonstrated that both Dmel\HATs are differentially expressed throughout Drosophila development. These results suggest that, in addition to being regulated by specific protein partners (MARMORSTEIN and ROTH 2001), HAT activity may also be controlled, at least in part, by their developmental regulation. In support of this idea is the observation that mice heterozygous for null alleles for each of the p300, CBP, and GCN5 HATs show less severe developmental defects than do homozygous null alleles, demonstrating that the overall dosage of HATs is critical for developmental processes (XU et al. 2000; ROTH et al. 2001). We also observed that both Dmel\TIP60 and Dmel\ELP3 expression peaked in the embryo, consistent with studies demonstrating the importance of chromatin control in early development (PATTERTON and WOLFFE 1996). Importantly, high levels of embryonic expression are not the case for all HATs as shown by studies demonstrating that GCN5 is expressed at high levels in the mouse embryo whereas expression levels of the HAT P/CAF are virtually undetectable (XU et al. 1998). These data, in conjunction with the HAT expression data reported here, suggest that only certain HATs may be essential for embryogenesis to proceed.
Although research on HATs in multicellular systems is still limited to date, knockout studies of p300, CBP (TANAKA et al. 1997; ROTH et al. 2003), and GCN5 (XU et al. 2000) in mice and of CBP (AKIMARU et al. 1997), HBO1 (GRIENENBERGER et al. 2002), and MOF (SMITH et al. 2001) in Drosophila have revealed essential roles for these HATs during development. Significantly, the phenotypic defects that arise from such different HAT knockouts are not identical. GCN5 is essential for mouse development and formation of several mesoderm tissues while PCAF is dispensable (XU et al. 2000), and differential roles for CBP and p300 in heart, lung, small intestine (SHIKAMA et al. 2003), and muscle development (ROTH et al. 2003) have been reported. Taken together, these studies indicate that HATs carry out specific functions required for proper multicellular development (ROTH et al. 2001). Here, we show that reducing endogenous Dmel\TIP60 expression by RNAi either in all tissues or specifically in the mesoderm/muscles of the developing fly results in lethality. Our results extend prior HAT knockout studies and add Dmel\TIP60 to the growing list of HATs that carry out potentially specialized roles essential for multicellular development.
Prior studies on the yeast TIP60 homolog ESA1 demonstrated that temperature-sensitive yeast esa1 mutant cells were found to be arrested during cell division with a G2/M stage DNA content and partially depleted acetylated H4 levels, thereby linking Esa1 HAT function to cell cycle control via potential transcriptional regulatory events (CLARKE et al. 1999). Consistent with these results, we observed that Dmel\TIP60 depletion in the Drosophila D.Mel-2 cell culture line resulted in a lethal phenotype reminiscent of mitotic cell cycle progression defects. Cells that did survive were larger than wild-type and control cells and appeared unable to complete cytokinesis, supporting a role for Dmel\TIP60 in metazoan embryonic cell division. We also found that either ubiquitous or mesoderm/muscle-specific depletion of Dmel\TIP60 in our GAL4-inducible HAT knockdown system resulted in lethality for all three independent Dmel\TIP60/RNAi insertion fly lines tested, with the majority of flies dying during early pupal development. Thus, as development proceeds, depletion of Dmel\TIP60 may result in the disruption of cell processes shown to require Dmel\TIP60, such as cell cycle progression (CLARKE et al. 1999), apoptosis (IKURA et al. 2000; LEGUBE et al. 2004), and DNA repair (BIRD et al. 2002), as well as disruption of cell-type-specific developmental pathways, culminating in lethality caused by an accumulation of cell defects that accrue over time, all possibilities that we are currently exploring.
HATs execute acetylation profiles required for target gene regulation and thus their misregulation is linked to numerous types of cancers and developmental defects (PETRIJ et al. 1995; MAHLKNECHT et al. 2000; STEFFAN et al. 2001; ROELFSEMA et al. 2005; CLOSE et al. 2006). The importance of TIP60 is underscored by studies demonstrating its involvement in both normal cellular processes and abnormal ones resulting in oncogenesis and developmental disorders. For example, overproduction of Tip60 in the nucleus of prostate cells is associated with androgen-resistant prostate cancer (HALKIDOU et al. 2003; SAPOUNTZI et al. 2006). Tip60 is also associated with numerous disease-related proteins, including the c-MYC oncoprotein (FRANK et al. 2003; PATEL et al. 2004), proteins involved in hematological malignancies (CHAMBERS et al. 2003; NORDENTOFT and JORGENSEN 2003), and Alzheimer's-associated amyloid precursor protein (APP) (BAEK et al. 2002; KIM et al. 2004). Interestingly, overproduction of the C terminus of APP induces an increase in histone acetylation that significantly enhances neurotoxicity, implicating Tip60 HAT mistargeting in Alzheimer's disease (KIM et al. 2004). Our isolation and characterization of Dmel\TIP60, in conjunction with our newly developed inducible and targeted HAT knockdown system in Drosophila, will allow us to effectively study the roles of TIP60 and other chromatin regulators in both multicellular development and epigenetic-based disorders.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| LITERATURE CITED |
|---|
|
|
|---|
AKIMARU, H., Y. CHEN, P. DAI, D. X. HOU, M. NONAKA et al., 1997 Drosophila CBP is a co-activator of cubitus interruptus in hedgehog signalling. Nature 386: 735–738.[CrossRef][Medline]
ALLAND, L., R. MUHLE, H. HOU, JR., J. POTES, L. CHIN et al., 1997 Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387: 49–55.[CrossRef][Medline]
ALLARD, S., R. T. UTLEY, J. SAVARD, A. CLARKE, P. GRANT et al., 1999 NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esa1p and the ATM-related cofactor Tra1p. EMBO J. 18: 5108–5119.[CrossRef][Medline]
BAEK, S. H., K. A. OHGI, D. W. ROSE, E. H. KOO, C. K. GLASS et al., 2002 Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110: 55–67.[CrossRef][Medline]
BERGER, S. L., 2001 An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene 20: 3007–3013.[CrossRef][Medline]
BERGER, S. L., 2002 Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12: 142–148.[CrossRef][Medline]
BIRD, A. W., D. Y. YU, M. G. PRAY-GRANT, Q. QIU, K. E. HARMON et al., 2002 Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair. Nature 419: 411–415.[CrossRef][Medline]
BOTTOMLEY, M. J., 2004 Structures of protein domains that create or recognize histone modifications. EMBO Rep 5: 464–469.[CrossRef][Medline]
BRAND, A. H., and N. PERRIMON, 1993 Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401–415.[Abstract]
CEOL, C. J., and H. R. HORVITZ, 2004 A new class of C. elegans synMuv genes implicates a Tip60/NuA4-like HAT complex as a negative regulator of Ras signaling. Dev. Cell 6: 563–576.[CrossRef][Medline]
CHAMBERS, A. E., S. BANERJEE, T. CHAPLIN, J. DUNNE, S. DEBERNARDI et al., 2003 Histone acetylation-mediated regulation of genes in leukaemic cells. Eur. J. Cancer 39: 1165–1175.[CrossRef][Medline]
CHAVOUS, D. A., F. R. JACKSON and C. M. O'CONNOR, 2001 Extension of the Drosophila lifespan by overexpression of a protein repair methyltransferase. Proc. Natl. Acad. Sci. USA 98: 14814–14818.
CHIEN, S., L. T. REITER, E. BIER and M. GRIBSKOV, 2002 Homophila: human disease gene cognates in Drosophila. Nucleic Acids Res. 30: 149–151.
CLARKE, A. S., J. E. LOWELL, S. J. JACOBSON and L. PILLUS, 1999 Esa1p is an essential histone acetyltransferase required for cell cycle progression. Mol. Cell. Biol. 19: 2515–2526.
CLOSE, P., N. HAWKES, I. CORNEZ, C. CREPPE, C. A. LAMBERT et al., 2006 Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol. Cell 22: 521–531.[CrossRef][Medline]
COOKE, N., Y. HO, B. SHEWCHUK, A. KIMURA, F. ELEFANT et al., 2004 Distinct epigenetic pathways activate the human growth hormone genes in pituitary and placenta, pp. 79–85 in 12th International Congress of Endocrinology, Medimond International Proceedings. Monduzzi Editore, Bologna, Italy.
DOYON, Y., and J. COTE, 2004 The highly conserved and multifunctional NuA4 HAT complex. Curr. Opin. Genet. Dev. 14: 147–154.[CrossRef][Medline]
ELEFANT, F., and K. B. PALTER, 1999 Tissue-specific expression of dominant negative mutant Drosophila HSC70 causes developmental defects and lethality. Mol. Biol. Cell 10: 2101–2117.
ELEFANT, F., N. E. COOKE and S. A. LIEBHABER, 2000a Targeted recruitment of histone acetyltransferase activity to a locus control region. J. Biol. Chem. 275: 13827–13834.
ELEFANT, F., Y. SU, S. A. LIEBHABER and N. E. COOKE, 2000b Patterns of histone acetylation suggest dual pathways for gene activation by a bifunctional locus control region. EMBO J. 19: 6814–6822.[CrossRef][Medline]
FERNANDEZ, L. A., M. WINKLER and R. GROSSCHEDL, 2001 Matrix attachment region-dependent function of the immunoglobulin mu enhancer involves histone acetylation at a distance without changes in enhancer occupancy. Mol. Cell. Biol. 21: 196–208.
FISCHLE, W., Y. WANG and C. D. ALLIS, 2003 Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15: 172–183.[CrossRef][Medline]
FLYBASE, 1999 The FlyBase database of the Drosophila Genome Projects and community literature. The FlyBase Consortium. Nucleic Acids Res. 27: 85–88.
FORTIER, E., and J. M. BELOTE, 2000 Temperature-dependent gene silencing by an expressed inverted repeat in Drosophila. Genesis 26: 240–244.[CrossRef][Medline]
FRANK, S. R., T. PARISI, S. TAUBERT, P. FERNANDEZ, M. FUCHS et al., 2003 MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 4: 575–580.[CrossRef][Medline]
FYRBERG, E. A., S. I. BERNSTEIN and K. VIJAYRAGHAVAN, 1994 Basic methods for Drosophila muscle biology. Methods Cell Biol. 44: 237–258.[Medline]
GRIENENBERGER, A., B. MIOTTO, T. SAGNIER, G. CAVALLI, V. SCHRAMKE et al., 2002 The MYST domain acetyltransferase Chameau functions in epigenetic mechanisms of transcriptional repression. Curr. Biol. 12: 762–766.[CrossRef][Medline]
HAKE, S. B., A. XIAO and C. D. ALLIS, 2004 Linking the epigenetic language of covalent histone modifications to cancer. Br. J. Cancer 90: 761–769.[CrossRef][Medline]
HALKIDOU, K., V. J. GNANAPRAGASAM, P. B. MEHTA, I. R. LOGAN, M. E. BRADY et al., 2003 Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene 22: 2466–2477.[CrossRef][Medline]
HALKIDOU, K., I. R. LOGAN, S. COOK, D. E. NEAL and C. N. ROBSON, 2004 Putative involvement of the histone acetyltransferase Tip60 in ribosomal gene transcription. Nucleic Acids Res. 32: 1654–1665.
HAWKES, N. A., G. OTERO, G. S. WINKLER, N. MARSHALL, M. E. DAHMUS et al., 2002 Purification and characterization of the human elongator complex. J. Biol. Chem. 277: 3047–3052.
HEBBES, T. R., A. L. CLAYTON, A. W. THORNE and C. CRANE-ROBINSON, 1994 Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken beta-globin chromosomal domain. EMBO J. 13: 1823–1830.[Medline]
HO, Y., F. ELEFANT, N. COOKE and S. LIEBHABER, 2002 A defined locus control region determinant links chromatin domain acetylation with long-range gene activation. Mol. Cell 9: 291–302.[CrossRef][Medline]
IIZUKA, M., and B. STILLMAN, 1999 Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the human initiator protein. J. Biol. Chem. 274: 23027–23034.
IKURA, T., V. V. OGRYZKO, M. GRIGORIEV, R. GROISMAN, J. WANG et al., 2000 Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102: 463–473.[CrossRef][Medline]
KENNERDELL, J. R., and R. W. CARTHEW, 2000 Heritable gene silencing in Drosophila using double-stranded RNA. Nat. Biotechnol. 18: 896–898.[CrossRef][Medline]
KIM, H. S., E. M. KIM, N. J. KIM, K. A. CHANG, Y. CHOI et al., 2004 Inhibition of histone deacetylation enhances the neurotoxicity induced by the C-terminal fragments of amyloid precursor protein. J. Neurosci. Res. 75: 117–124.[CrossRef][Medline]
KUSCH, T., L. FLORENS, W. H. MACDONALD, S. K. SWANSON, R. L. GLASER et al., 2004 Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 306: 2084–2087.
LEGUBE, G., L. K. LINARES, S. TYTECA, C. CARON, M. SCHEFFNER et al., 2004 Role of the histone acetyl transferase Tip60 in the p53 pathway. J. Biol. Chem. 279: 44825–44833.
LI, B., C. RUAN and J. L. WORKMAN, 2005 Histones: Should I stay or should I go? Genome Biol. 6: 306.[CrossRef][Medline]
LOUGH, J. W., 2002 Transient expression of TIP60 protein during early chick heart development. Dev. Dyn. 223: 419–425.[CrossRef][Medline]
LUDLAM, W. H., M. H. TAYLOR, K. G. TANNER, J. M. DENU, R. H. GOODMAN et al., 2002 The acetyltransferase activity of CBP is required for wingless activation and H4 acetylation in Drosophila melanogaster. Mol. Cell. Biol. 22: 3832–3841.
MAHLKNECHT, U., O. G. OTTMANN and D. HOELZER, 2000 When the band begins to play: histone acetylation caught in the crossfire of gene control. Mol. Carcinog. 27: 268–271.[CrossRef][Medline]
MARMORSTEIN, R., and S. Y. ROTH, 2001 Histone acetyltransferases: function, structure, and catalysis. Curr. Opin. Genet. Dev. 11: 155–161.[CrossRef][Medline]
MCALLISTER, D., X. MERLO and J. LOUGH, 2002 Characterization and expression of the mouse tat interactive protein 60 kD (TIP60) gene. Gene 289: 169–176.[CrossRef][Medline]
MORRISON, A. J., and X. SHEN, 2005 DNA repair in the context of chromatin. Cell Cycle 4: 568–571.[Medline]
NORDENTOFT, I., and P. JORGENSEN, 2003 The acetyltransferase 60 kDa trans-acting regulatory protein of HIV type 1-interacting protein (Tip60) interacts with the translocation E26 transforming-specific leukaemia gene (TEL) and functions as a transcriptional co-repressor. Biochem. J. 374: 165–173.[CrossRef][Medline]
NOWAK, S. J., and V. G. CORCES, 2000 Phosphorylation of histone H3 correlates with transcriptionally active loci. Genes Dev. 14: 3003–3013.
ORPHANIDES, G., and D. REINBERG, 2002 A unified theory of gene expression. Cell 108: 439–451.[CrossRef][Medline]
PATEL, J. H., Y. DU, P. G. ARD, C. PHILLIPS, B. CARELLA et al., 2004 The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol. Cell. Biol. 24: 10826–10834.
PATTERTON, D., and A. P. WOLFFE, 1996 Developmental roles for chromatin and chromosomal structure. Dev. Biol. 173: 2–13.[CrossRef][Medline]
PETRIJ, F., R. H. GILES, H. G. DAUWERSE, J. J. SARIS, R. C. HENNEKAM et al., 1995 Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376: 348–351.[CrossRef][Medline]
REID, J. L., V. R. IYER, P. O. BROWN and K. STRUHL, 2000 Coordinate regulation of yeast ribosomal protein genes is associated with targeted recruitment of Esa1 histone acetylase. Mol. Cell 6: 1297–1307.[CrossRef][Medline]
RICE, J. C., and C. D. ALLIS, 2001 Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol. 13: 263–273.[CrossRef][Medline]
ROELFSEMA, J. H., S. J. WHITE, Y. ARIYUREK, D. BARTHOLDI, D. NIEDRIST et al., 2005 Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am. J. Hum. Genet. 76: 572–580.[CrossRef][Medline]
ROLLINS, R. A., M. KOROM, N. AULNER, A. MARTENS and D. DORSETT, 2004 Drosophila nipped-B protein supports sister chromatid cohesion and opposes the stromalin/Scc3 cohesion factor to facilitate long-range activation of the cut gene. Mol. Cell. Biol. 24: 3100–3111.
ROTH, J. F., N. SHIKAMA, C. HENZEN, I. DESBAILLETS, W. LUTZ et al., 2003 Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5. EMBO J. 22: 5186